tiprankstipranks
Editas Medicine Inc (EDIT)
NASDAQ:EDIT
US Market
EDIT
Editas Medicine
RESEARCH TOOLSreports
Want to see EDIT full AI Analyst Report?

Editas Medicine (EDIT) Stock News & Sentiment

3,578 Followers
Editas Medicine Shareholders Back Board, Pay and Auditor
Premium
Company Announcements
Editas Medicine Shareholders Back Board, Pay and Auditor
1M ago
8K
EDIT
Editas Medicine Raises Capital Through Public Equity Offering
Premium
Company Announcements
Editas Medicine Raises Capital Through Public Equity Offering
2M ago
8K
EDIT
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
Premium
Company Announcements
Editas Medicine Suspends Existing At-The-Market Offering Prospectus
2M ago
8K
EDIT
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
Premium
Company Announcements
Editas Showcases Promising EDIT-401 Data for Hyperlipidemia
2M ago
8K
EDIT
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
Premium
Ratings
Analyst Maintains Buy on Editas Medicine, Reiterates $5 Price Target on EDIT-401 Progress and Strong Cash Runway
2M ago
EDIT
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
Premium
Company Announcements
Editas Showcases Promising EDIT-401 Hyperlipidemia Preclinical Data
2M ago
8K
EDIT
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
Premium
Ratings
Analyst Phil Nadeau Reiterates Buy on Editas Medicine, Citing Promising EDIT-401 Data, Strong Cash Runway, and Large Untapped HeFH Opportunity
3M ago
EDIT
More EDIT News >

EDIT News on the Web

Editas Medicine Inc Annual Shareholders Meeting Transcript
GuruFocus News
Neutral
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026?
The Motley Fool
Bearish
CRISPR Therapeutics vs. Editas Medicine: Which Gene Editing Stock Is a Better Buy in 2026? | The Motley Fool
Motley Fool
Bearish
Top Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX
rttnews
Bullish
Editas Medicine’s $319.4M Offering Signals Major Cash Infusion—and Sets Critical Clinical Milestones
Market Chameleon
Neutral
TD Cowen remains bullish on Editas Medicine after ‘compelling preclinical data’
TipRanks News
Bullish
Editas Medicine preclinical data ‘looks highly supportive,’ says Evercore ISI
TipRanks News
Bullish
Editas Medicine Raises Capital Through Public Equity Offering
TipRanks News
Neutral

News Score - Last 7 Days

Not enough data to generate a sentiment score
Media Buzz
This Week0 articles
Weekly Average2.5 articles
News Sentiment
Currently, no data available
See how Bullish or Bearish a stock is based on its recent media coverage.

This score is generated using a formula that combines Media Buzz and News Sentiment.

Media Coverage Analysis

The historical news coverage of this asset in the last three months.

FAQ

What is EDIT’s Media Buzz Sentiment?
Currently, no data Available
What is EDIT’s weekly average amount of articles?
In an average week, 2.5 articles about EDIT are published.
    What is EDIT’s News Sentiment?
    Currently, no data Available
    Healthcare Stocks that are Trending in the News
    ATAIAtai Beckley N.V.
    UNHUnitedHealth
    CELCCelcuity
    ABTAbbott Laboratories
    NXTCNextCure
    Showing the stocks with the most bullish news sentiment over the past week